Showing 4,501 - 4,520 results of 4,694 for search '(( significant decrease decrease ) OR ( significance test decrease ))~', query time: 0.54s Refine Results
  1. 4501

    Table1_Chaihu Shugan powder restores fatty acid synthesis to alleviate insulin resistance in metabolic syndrome by regulating the LXRα/SREBP-1 signaling pathway.XLSX by Sisi Lei (10999575)

    Published 2024
    “…Background<p>Metabolic syndrome (MS) is a significant risk factor for cardiovascular and cerebrovascular diseases, primarily driven by insulin resistance (IR). …”
  2. 4502

    Table 1_Associated effects of lipopolysaccharide, oleic acid, and lung injury ventilator-induced in developing a model of moderate acute respiratory distress syndrome in New Zealan... by Xingyu Tian (17791894)

    Published 2025
    “…The LOV group showed the most severe lung injury, significantly decreasing MAP and Cdyn. Pathological and ultrasound scores were considerably higher in the LOV group compared to the OM and LOM groups (p < 0.05). …”
  3. 4503

    Table 1_COVID-19 pandemic increased ESKAPEEc bloodstream infections and amplified carbapenem resistance in Chinese children: a multicenter surveillance study (2016–2023).xls by Xiaoqiang Li (612879)

    Published 2025
    “…Methicillin-susceptible Staphylococcus aureus (MSSA) strains had lower vancomycin MIC ≥2 μg/mL levels compared to methicillin-resistant Staphylococcus aureus (MRSA) strains. Significant temporal differences were observed in MRSA isolates with linezolid MIC ≥2 μg/mL but not in MSSA isolates. …”
  4. 4504

    Data Sheet 1_Microbiota profiling from biopsied tissues in complex infections: a diagnostic and prognostic analysis through metagenomic next-generation sequencing.docx by Tiange Song (13878401)

    Published 2025
    “…Early mNGS sampling within 7 days after admission was associated with a significantly decreased risk of all-cause mortality (HR 0.18, 95% CI 0.04–0.94; P=0.04), treatment failure (OR 0.17, 95% CI 0.05–0.66; P=0.01), and increased probability of clinical resolution (OR 3.03, 95% CI 1.24–7.40; P=0.01).…”
  5. 4505

    Image 1_Ketogenic diet–induced changes in methylation status and neuropeptide signaling: relationships between S-adenosylmethionine (AdoMet), orexin-A, and metabolic health.pdf by Laura Mosca (704904)

    Published 2025
    “…Circulating AdoMet (−75.7%) and Orexin-A (−7.2%) levels also decreased significantly. AdoMet levels positively correlated with body weight, BMI, visceral adipose tissue, total cholesterol, fasting glycemia, triglycerides, HbA1c, and notably Orexin-A (R<sup>2</sup> = 0.3848, p < 0.0001).…”
  6. 4506
  7. 4507

    Supplementary Material for: Head positioning for stroke blood flow augmentation assisting reperfusion therapies (HEAD-START) study by figshare admin karger (2628495)

    Published 2025
    “…Trendelenburg positioning was maintained for 24h if lesion volume significantly decreased (≥5mL) and stroke reperfusion was suboptimal or undetermined. …”
  8. 4508

    Table 1_Glucose and lipid metabolism in non-diabetic, non-obese patients with obstructive sleep apnea: sex differences.docx by Yuhan Wang (595964)

    Published 2025
    “…The high-density lipoprotein cholesterol (HDL-C) level in OSA participants was significantly lower (0.99 vs. 1.12 mmol/L, p = 0.036), and the triglyceride-glucose (TyG) index was significantly higher (8.74 vs. 8.45, p = 0.016), while there was no significant difference in the levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and non-HDL-C. …”
  9. 4509

    Table 1_Study on Chaiyuwendan decoction’s inhibition of hippocampal neuron apoptosis to alleviating depression by activating the AKT/CREB pathway.docx by Shaoliang Zhang (7523498)

    Published 2025
    “…Chaiyuwendan decoction (CYWD) has significant clinical efficacy in treating depression, however, its specific mechanism is still unclear. …”
  10. 4510

    Table 1_Association of MIF rs1007888 and ARAP1 rs1552224 genetic variants with the risk of gestational diabetes mellitus in a chinese population; case study and meta-analysis.xlsx by Yuxuan Zhang (1425721)

    Published 2025
    “…Background<p>Macrophage migration inhibitory factor (MIF) rs1007888 is significantly associated with pancreatic β-cell function and insulin resistance in patients with gestational diabetes mellitus (GDM). …”
  11. 4511

    Table 2_Association of MIF rs1007888 and ARAP1 rs1552224 genetic variants with the risk of gestational diabetes mellitus in a chinese population; case study and meta-analysis.xlsx by Yuxuan Zhang (1425721)

    Published 2025
    “…Background<p>Macrophage migration inhibitory factor (MIF) rs1007888 is significantly associated with pancreatic β-cell function and insulin resistance in patients with gestational diabetes mellitus (GDM). …”
  12. 4512

    Table 6_Association of MIF rs1007888 and ARAP1 rs1552224 genetic variants with the risk of gestational diabetes mellitus in a chinese population; case study and meta-analysis.xlsx by Yuxuan Zhang (1425721)

    Published 2025
    “…Background<p>Macrophage migration inhibitory factor (MIF) rs1007888 is significantly associated with pancreatic β-cell function and insulin resistance in patients with gestational diabetes mellitus (GDM). …”
  13. 4513

    Table 4_Association of MIF rs1007888 and ARAP1 rs1552224 genetic variants with the risk of gestational diabetes mellitus in a chinese population; case study and meta-analysis.xlsx by Yuxuan Zhang (1425721)

    Published 2025
    “…Background<p>Macrophage migration inhibitory factor (MIF) rs1007888 is significantly associated with pancreatic β-cell function and insulin resistance in patients with gestational diabetes mellitus (GDM). …”
  14. 4514

    Table 5_Association of MIF rs1007888 and ARAP1 rs1552224 genetic variants with the risk of gestational diabetes mellitus in a chinese population; case study and meta-analysis.xlsx by Yuxuan Zhang (1425721)

    Published 2025
    “…Background<p>Macrophage migration inhibitory factor (MIF) rs1007888 is significantly associated with pancreatic β-cell function and insulin resistance in patients with gestational diabetes mellitus (GDM). …”
  15. 4515

    Table 3_Association of MIF rs1007888 and ARAP1 rs1552224 genetic variants with the risk of gestational diabetes mellitus in a chinese population; case study and meta-analysis.xlsx by Yuxuan Zhang (1425721)

    Published 2025
    “…Background<p>Macrophage migration inhibitory factor (MIF) rs1007888 is significantly associated with pancreatic β-cell function and insulin resistance in patients with gestational diabetes mellitus (GDM). …”
  16. 4516

    Table 7_Association of MIF rs1007888 and ARAP1 rs1552224 genetic variants with the risk of gestational diabetes mellitus in a chinese population; case study and meta-analysis.xlsx by Yuxuan Zhang (1425721)

    Published 2025
    “…Background<p>Macrophage migration inhibitory factor (MIF) rs1007888 is significantly associated with pancreatic β-cell function and insulin resistance in patients with gestational diabetes mellitus (GDM). …”
  17. 4517

    Data Sheet 1_Association of MIF rs1007888 and ARAP1 rs1552224 genetic variants with the risk of gestational diabetes mellitus in a chinese population; case study and meta-analysis.... by Yuxuan Zhang (1425721)

    Published 2025
    “…Background<p>Macrophage migration inhibitory factor (MIF) rs1007888 is significantly associated with pancreatic β-cell function and insulin resistance in patients with gestational diabetes mellitus (GDM). …”
  18. 4518

    SEAwise synthesis of predicted impacts of changes in habitat and spatial management measures suggested in SEAwise for online tool by Dimitris Damalas (15976639)

    Published 2025
    “…</li></ul><p dir="ltr">The scenarios investigated in SEAwise suggest that prohibition of certain fishing practices, not only in currently designed MPAs but also in fit-to-purpose areas to limit the risk of incidental species and the degradation of benthic status, will significantly impact the overall fisheries economy and fish populations. …”
  19. 4519

    SEAwise Report on the impacts of fisheries on stocks and landings under SEAwise EBFM by Dorleta Garcia (12315201)

    Published 2025
    “…The ecosystem model generally showed less optimistic outcomes under climate change, with significant decreases in biomass and catches in both the Celtic and North Seas. …”
  20. 4520

    DataSheet1_Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD.doc by Hyun-ju Lee (7550741)

    Published 2024
    “…</p>Results and discussion<p>We found that erlotinib significantly enhanced short-term spatial memory and dendritic spine formation in 6-month-old P301S tau transgenic (PS19) mice. …”